News

By Sriparna Roy (Reuters) -Privately held Stealth BioTherapeutics said on Thursday the U.S. Food and Drug Administration had ...
Spun off from Novartis in 2019, Alcon is betting on new product launches to accelerate sales growth in the second half of ...
Instead of approving Stealth BioTherapeutics' drug for Barth syndrome, the FDA withheld its endorsement, but decided it may ...
“Reported cases were rare but sometimes serious, with patients experiencing widespread, severe itching that required medical ...
Instead, Stealth submitted a new drug application (NDA) seeking approval of elamipretide and the FDA issued its ...
In a significant shift this week, Health Secretary Robert F. Kennedy Jr. announced that COVID-19 vaccines will no longer be recommended for healthy children and pregnant individuals. That sparked ...
The U.S. Food and Drug Administration cleared the first in vitro diagnostic device that tests blood to aid in diagnosing ...
FDA warns of severe itching risk when stopping long-term use of allergy medications cetirizine and levocetirizine, affecting ...
Health Secretary Robert F. Kennedy Jr.’s decision to revoke the Covid vaccine recommendation for pregnant women has raised ...
Previously, updated COVID vaccines had been recommended annually by the CDC for everyone over the age of 6 months. The CDC ...
The FDA will no longer recommend annual COVID vaccinations for healthy people younger than 65. This means that if you are ...
If coronavirus vaccines are restricted to seniors and those at high risk, parents of young children and relatives of ...